医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Toyoda Gosei Develops Urethane Microfoam Film to Cultivate Cells for Drug Discovery

2020年11月04日 PM01:00
このエントリーをはてなブックマークに追加


 

KIYOSU, Japan

Toyoda Gosei Co., Ltd. (TOKYO:7282) has developed a urethane microfoam film for cell culture, using the knowledge of urethane materials it has gained in the development and production of steering wheels. This film allows cells to be cultivated with a structure close to that of certain living tissues, and is promising as an alternative to animal experiments and for other uses in new drug development. The company is currently conducting pharmacokinetic studies* for early practical application.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201103005814/en/

Image of cell culture (Graphic: Business Wire)

Image of cell culture (Graphic: Business Wire)

A key feature of the urethane film is that two kinds of cells can be cultivated in a two-layered tissue structure close to that of living tissues such as blood vessels and the intestinal epithelium. This is achieved with the film’s ability not only to separate the two kinds of cells on opposite sides of the film and keep them from mixing with each other, but also to allow the two kinds of cells to contact each other through countless U-shaped through pores in the film. The size of these pores can be controlled at the micrometer level.

In new drug development, this two-cell layer tissue will enable detailed examination of the movement of a drug in individual cell layers similar to those in the living body. This will lead to alternatives to some animal experiments, which are used to assess drug efficacy and safety, and help to narrow the list of candidate drugs in the early phase. In this way it will contribute to shorter development periods and lower development costs.

Toyoda Gosei will continue to leverage its core technologies to contribute to medical advances.

Toyoda Gosei will announce this technology at the 33rd Annual Meeting of the Japanese Society for Alternatives to Animal Experiments held online on 12 and 13 November.

Name

The 33rd Annual Meeting of the Japanese Society
for Alternatives to Animal Experiments

Dates

12 and 13 November 2020 (All day)

Venue

Website (URL https://jsaae33.secand.net/english.html)

Theme

Double layered co-culture for direct interaction between Caco-2 and human vein endothelial cells by using the membrane with U-shaped through pore

 *In vitro studies to assess a drug’s benefits and side effects by investigating the drug’s activities (cell absorption, distribution, metabolism and excretion).

View source version on businesswire.com: https://www.businesswire.com/news/home/20201103005814/en/

CONTACT

Toyoda Gosei Co., Ltd.

Chihiro Suzuki

inquiry@mail.toyoda-gosei.co.jp

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Sherlock Biosciences Strengthens Intellectual Property Portfolio in CRISPR-based Diagnostics Through Exclusive License Agreement with Tolo Biotech
  • New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint
  • Shape Therapeutics推出AAVid™衣壳发现平台和新型组织特异性AAV变异识别,解决基因治疗根本性的投药挑战
  • Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates
  • 三叶草生物发布其“S-三聚体”重组亚单位新冠候选疫苗 I 期临床研究积极结果